When we performed migration and invasion assays we found that reduced EFTUD2 levels actually correlated with decreased migration (Fig. 6D and Supplementary Fig. S7C) and invasion (Fig. 6E and Supplementary Fig. S7D), fully confirming that EFTUD2 is indeed a bona fide gene with oncogenic functions in MM. The gene discussed is EFTUD2; the disease is Miyoshi myopathy.